Immunolocalization of urotensin II and its receptor in human adrenal tumors and attached non-neoplastic adrenal tissues

Peptides

Volumn 29, Issue 5, 2008, Pages 873-880

  Morimoto, Ryo ^a   Satoh, Fumitoshi ^a   Murakami, Osamu ^a   Totsune, Kazuhito ^a   Arai, Yoichi ^a   Suzuki, Takashi ^b   Sasano, Hironobu ^a   Ito, Sadayoshi ^a   Takahashi, Kazuhiro ^b  

^a TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b TOHOKU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Adrenal tumor; Immunohistochemistry; Urotensin II; Urotensin II receptor

Indexed keywords

ALDOSTERONE; HYDROCORTISONE; RECEPTOR; UNCLASSIFIED DRUG; UROTENSIN II; UROTENSIN II RECEPTOR;

ADRENAL CORTEX; ADRENAL CORTEX ADENOMA; ADRENAL CORTEX CARCINOMA; ADRENAL MEDULLA; ADRENAL TUMOR; ADULT; AGED; ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOLOCALIZATION; IMMUNOREACTIVITY; MALE; PHEOCHROMOCYTOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; TISSUE SECTION; TUMOR CELL; UPREGULATION;

ADRENAL GLAND NEOPLASMS; ADRENAL GLANDS; ADULT; AGED; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; RECEPTORS, G-PROTEIN-COUPLED; UROTENSINS;

CALLOGOBIUS ATRATUS;

EID: 42049086269     PISSN: 01969781     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.peptides.2007.06.025     Document Type: Article

References (51)

1. Adrian T.E., Allen J.M., Terenghi G., Bacarese-Hamilton A.J., Brown M.J., Polak J.M., et al. In phaeochromocytomas and ganglioneuroblastomas. Lancet 2 (1983) 540-542
2. Albertin G., Carraro G., Petrelli L., Guidolin D., Neri G., and Nussdorfer G.G. Endothelin-1 and adrenomedullin enhance the growth of human adrenocortical carcinoma-derived SW-13 cell line by stimulating proliferation and inhibiting apoptosis. Int J Mol Med 15 (2005) 469-474
3. Albertin G., Casale V., Ziolkowska A., Spinazzi R., Malendowicz L.K., Rossi G.P., et al. Urotensin-II and UII-receptor expression and function in the rat adrenal cortex. Int J Mol Med 17 (2006) 1111-1115
4. Ames R.S., Sarau H.M., Chambers J.K., Willette R.N., Aiyar N.V., Romanic A.M., et al. Human urotensin-II is a potent vasoconstrictor and agonist for the orphan receptor GPR14. Nature 401 (1999) 282-286
5. Arnold-Reed D.E., and Balment R.J. Peptide hormones influence in vitro interrenal secretion of cortisol in the trout, Oncorhynchus mykiss. Gen Comp Endocrinol 96 (1994) 85-91
6. Ashton N. Renal and vascular actions of urotensin II. Kidney Int 70 (2006) 624-629
7. Bern H.A., and Lederis K. A reference preparation for the study of active substances in the caudal neurosecretory system of teleosts. J Endocrinol 45 Suppl (1969) xi-xii
8. Bousette N., Patel L., Douglas S.A., Ohlstein E.H., and Giaid A. Increased expression of urotensin II and its cognate receptor GPR14 in atherosclerotic lesions of the human aorta. Atherosclerosis 176 (2004) 117-123
9. Clozel M., Binkert C., Birker-Robaczewska M., Boukhadra C., Ding S.S., Fischli W., et al. Pharmacology of the urotensin-II receptor antagonist palosuran (ACT-058362; 1-[2-(4-benzyl-4-hydroxy-piperidin-1-yl)-ethyl]-3-(2-methyl-quinolin-4-yl)-urea sulfate salt): first demonstration of a pathophysiological role of the urotensin system. J Pharmacol Exp Ther 311 (2004) 204-212
10. Coulouarn Y., Jegou S., Tostivint H., Vaudry H., and Lihrmann I. Cloning, sequence analysis and tissue distribution of the mouse and rat urotensin II precursors. FEBS Lett 457 (1999) 28-32
11. Coulouarn Y., Lihrmann I., Jegou S., Anouar Y., Tostivint H., Beauvillain J.C., et al. Cloning of the cDNA encoding the urotensin II precursor in frog and human reveals intense expression of the urotensin II gene in motoneurons of the spinal cord. Proc Natl Acad Sci USA 95 (1998) 15803-15808
12. Elshourbagy N.A., Douglas S.A., Shabon U., Harrison S., Duddy G., Sechler J.L., et al. Molecular and pharmacological characterization of genes encoding urotensin-II peptides and their cognate G-protein-coupled receptors from the mouse and monkey. Br J Pharmacol 136 (2002) 9-22
13. Fukuda T., Takahashi K., Suzuki T., Saruta M., Watanabe M., Nakata T., et al. Urocortin 1, urocortin 3/stresscopin, and corticotropin-releasing factor receptors in human adrenal and its disorders. J Clin Endocrinol Metab 90 (2005) 4671-4678
14. Hood S.G., Watson A.M., and May C.N. Cardiac actions of central but not peripheral urotensin II are prevented by beta-adrenoceptor blockade. Peptides 26 (2005) 1248-1256
15. Kelsall C.J., and Balment R.J. Native urotensins influence cortisol secretion and plasma cortisol concentration in the euryhaline flounder, platichthys flesus. Gen Comp Endocrinol 112 (1998) 210-219
16. Lin Y., Tsuchihashi T., Matsumura K., Fukuhara M., Ohya Y., Fujii K., et al. Central cardiovascular action of urotensin II in spontaneously hypertensive rats. Hypertens Res 26 (2003) 839-845
17. Liu Q., Pong S.S., Zeng Z., Zhang Q., Howard A.D., Williams Jr. D.L., et al. Identification of urotensin II as the endogenous ligand for the orphan G-protein-coupled receptor GPR14. Biochem Biophys Res Commun 266 (1999) 174-178
18. Lundberg J.M., Hamberger B., Schultzberg M., Hokfelt T., Granberg P.O., Efendic S., et al. Enkephalin- and somatostatin-like immunoreactivities in human adrenal medulla and pheochromocytoma. Proc Natl Acad Sci USA 76 (1979) 4079-4083
19. Maguire J.J., Kuc R.E., and Davenport A.P. Orphan-receptor ligand human urotensin II: receptor localization in human tissues and comparison of vasoconstrictor responses with endothelin-1. Br J Pharmacol 131 (2000) 441-446
20. Maguire J.J., Kuc R.E., Wiley K.E., Kleinz M.J., and Davenport A.P. Cellular distribution of immunoreactive urotensin-II in human tissues with evidence of increased expression in atherosclerosis and a greater constrictor response of small compared to large coronary arteries. Peptides 25 (2004) 1767-1774
21. Matsushita M., Shichiri M., Fukai N., Ozawa N., Yoshimoto T., Takasu N., et al. Urotensin II is an autocrine/paracrine growth factor for the porcine renal epithelial cell line, LLCPK1. Endocrinology 144 (2003) 1825-1831
22. Matsushita M., Shichiri M., Imai T., Iwashina M., Tanaka H., Takasu N., et al. Co-expression of urotensin II and its receptor (GPR14) in human cardiovascular and renal tissues. J Hypertens 19 (2001) 2185-2190
23. Mori M., Sugo T., Abe M., Shimomura Y., Kurihara M., Kitada C., et al. Urotensin II is the endogenous ligand of a G-protein-coupled orphan receptor, SENR (GPR14). Biochem Biophys Res Commun 265 (1999) 123-129
24. Ng L.L., Loke I., O'Brien R.J., Squire I.B., and Davies J.E. Plasma urotensin in human systolic heart failure. Circulation 106 (2002) 2877-2880
25. Nothacker H.P., Wang Z., McNeill A.M., Saito Y., Merten S., O'Dowd B., et al. Identification of the natural ligand of an orphan G-protein-coupled receptor involved in the regulation of vasoconstriction. Nat Cell Biol 1 (1999) 383-385
26. Onan D., Hannan R.D., and Thomas W.G. Urotensin II: the old kid in town. Trends Endocrinol Metab 15 (2004) 175-182
27. Ong K.L., Lam K.S., and Cheung B.M. Urotensin II: its function in health and its role in disease. Cardiovasc Drugs Ther 19 (2005) 65-75
28. Richards A.M., and Charles C. Urotensin II in the cardiovascular system. Peptides 25 (2004) 1795-1802
29. Richards A.M., Nicholls M.G., Lainchbury J.G., Fisher S., and Yandle T.G. Plasma urotensin II in heart failure. Lancet 360 (2002) 545-546
30. Sasano H. Localization of steroidogenic enzymes in adrenal cortex and its disorders. Endocr J 41 (1994) 471-482
31. Satoh F., Takahashi K., Murakami O., Totsune K., Sone M., Ohneda M., et al. Immunocytochemical localization of adrenomedullin-like immunoreactivity in the human hypothalamus and the adrenal gland. Neurosci Lett 203 (1996) 207-210
32. Sauzeau V., Le Mellionnec E., Bertoglio J., Scalbert E., Pacaud P., and Loirand G. Human urotensin II-induced contraction and arterial smooth muscle cell proliferation are mediated by RhoA and Rho-kinase. Circ Res 88 (2001) 1102-1104
33. Spinazzi R., Albertin G., Nico B., Guidolin D., Di Liddo R., Rossi G.P., et al. Urotensin-II and its receptor (UT-R) are expressed in rat brain endothelial cells, and urotensin-II via UT-R stimulates angiogenesis in vivo and in vitro. Int J Mol Med 18 (2006) 1107-1112
34. Sugo T., Murakami Y., Shimomura Y., Harada M., Abe M., Ishibashi Y., et al. Identification of urotensin II-related peptide as the urotensin II-immunoreactive molecule in the rat brain. Biochem Biophys Res Commun 310 (2003) 860-868
35. Suzuki T., Sasano H., Sawai T., Tsunoda K., Nisikawa T., Abe K., et al. Small adrenocortical tumors without apparent clinical endocrine abnormalities. Immunolocalization of steroidogenic enzymes. Pathol Res Pract 188 (1992) 883-889
36. Takahashi K., Satoh F., Sone M., Totsune K., Arihara Z., Noshiro T., et al. Expression of adrenomedullin mRNA in adrenocortical tumors and secretion of adrenomedullin by cultured adrenocortical carcinoma cells. Peptides 19 (1998) 1719-1724
37. Takahashi K., Totsune K., and Murakami O. Adrenocortical peptides: autocrine or paracrine regulators for the steroid hormone secretion or the cell proliferation?. Exp Clin Endocrinol Diabetes 110 (2002) 373-380
38. Takahashi K., Totsune K., Murakami O., Arihara Z., Noshiro T., Hayashi Y., et al. Expression of urotensin II and its receptor in adrenal tumors and stimulation of proliferation of cultured tumor cells by urotensin II. Peptides 24 (2003) 301-306
39. Takahashi K., Totsune K., Murakami O., and Shibahara S. Expression of urotensin II and urotensin II receptor mRNAs in various human tumor cell lines and secretion of urotensin II-like immunoreactivity by SW-13 adrenocortical carcinoma cells. Peptides 22 (2001) 1175-1179
40. Takahashi K., Totsune K., Saruta M., Fukuda T., Suzuki T., Hirose T., et al. Expression of urocortin 3/stresscopin in human adrenal glands and adrenal tumors. Peptides 27 (2006) 178-182
41. Tamura K., Okazaki M., Tamura M., Isozumi K., Tasaki H., and Nakashima Y. Urotensin II-induced activation of extracellular signal-regulated kinase in cultured vascular smooth muscle cells: involvement of cell adhesion-mediated integrin signaling. Life Sci 72 (2003) 1049-1060
42. Tal M., Ammar D.A., Karpuj M., Krizhanovsky V., Naim M., and Thompson D.A. A novel putative neuropeptide receptor expressed in neural tissue, including sensory epithelia. Biochem Biophys Res Commun 209 (1995) 752-759
43. Totsune K., Takahashi K., Arihara Z., Sone M., Ito S., and Murakami O. Increased plasma urotensin II levels in patients with diabetes mellitus. Clin Sci (Lond) 104 (2003) 1-5
44. Totsune K., Takahashi K., Arihara Z., Sone M., Murakami O., Ito S., et al. Elevated plasma levels of immunoreactive urotensin II and its increased urinary excretion in patients with Type 2 diabetes mellitus: association with progress of diabetic nephropathy. Peptides 25 (2004) 1809-1814
45. Totsune K., Takahashi K., Arihara Z., Sone M., Satoh F., Ito S., et al. Role of urotensin II in patients on dialysis. Lancet 358 (2001) 810-811
46. Watanabe T., Pakala R., Katagiri T., and Benedict C.R. Synergistic effect of urotensin II with mildly oxidized LDL on DNA synthesis in vascular smooth muscle cells. Circulation 104 (2001) 16-18
47. Watson A.M., Lambert G.W., Smith K.J., and May C.N. Urotensin II acts centrally to increase epinephrine and ACTH release and cause potent inotropic and chronotropic actions. Hypertension 42 (2003) 373-379
48. Weiss L.M. Comparative histologic study of 43 metastasizing and nonmetastasizing adrenocortical tumors. Am J Surg Pathol 8 (1984) 163-169
49. Weiss L.M., Medeiros L.J., and Vickery Jr. A.L. Pathologic features of prognostic significance in adrenocortical carcinoma. Am J Surg Pathol 13 (1989) 202-206
50. Yoshimoto T., Matsushita M., and Hirata Y. Role of urotensin II in peripheral tissue as an autocrine/paracrine growth factor. Peptides 25 (2004) 1775-1781
51. Zeng Z.P., Liu G.Q., Li H.Z., Fan X.R., Liu D.M., Tong A.L., et al. The effects of urotensin-II on proliferation of pheochromocytoma cells and mRNA expression of urotensin-II and its receptor in pheochromocytoma tissues. Ann NY Acad Sci 1073 (2006) 284-289